Sterol ~100 microliters

Bile Acid ~100 microliters

Cytokine ~60 microliters

Days for Each WOL (Week of Life)

*DOL 1 = DOB

Days of Life of each week
Weeks Days
1 2-8
2 9-15
3 16-22
4 23-39
5 30-36
6 37-43
7 44-50
8 51-57
9 58-64
10 65-71
All Samples per Subject Per Week
id WEEK1 WEEK2 WEEK3 WEEK4 WEEK5 WEEK6 WEEK7 WEEK8 WEEK9 WEEK10 BL POST_TPN
1100 s c s c s c s c s c s s c
1101 c s c s c s c s c s c s s
1107 b c s c s c s s c s b c s
1108 b c s c s c s b c c s
1110 b c s c s s b c s
1111 b c b c s c s b c s
1114 s b c s b c s
1123 b s s
1125 c s b c s
1126 b c s c s c s
1128 c c
1150 b c s b c s
1162 b c s
1163 c s b c s s b c s b c s b c s b
1168 c s c
1169 c s
1173 b c s
1177 c c s
1185 b c s b c s
1186 b c s
1187 b c s b c s
1189 c s b c s
1190 s c s
1192 c s c s
1194 c c
1196 b c
1198 c c s
1200 c s

Growth Failure

Defined as a change in z-score (weight or length) from birth to discharge, where -0.8 to -1.19 is mild, -1.2 to -1.99 is moderate, and -2 or worse is severe. [weight or length z-score at discharge - weight or length z-score at birth] - worst delta score taken into account for categorizing.

Growth Failure
study_id delta_w_z delta_l_z growth_failure
1107 -0.11 -0.99 mild
1108 -0.99 -0.96 mild
1110 -1.12 96.07 mild
1114 -0.88 -0.20 mild
1123 -1.45 -1.70 moderate
1150 -2.05 -1.60 moderate
1168 -1.36 -0.34 moderate
1173 -2.95 -0.64 severe
1185 -2.46 -1.97 severe
1186 -2.21 -1.56 severe
1187 -1.97 -2.75 severe
1198 -2.18 -3.11 severe
Bile Acid Samples per Subject per Week
1 10 2 4 5 7 8 BL Post TPN
1107 1 0 0 0 0 0 0 0 1
1108 1 0 0 0 1 0 0 0 0
1110 1 0 0 0 0 0 0 0 1
1111 1 0 1 0 0 0 0 0 1
1114 0 0 0 1 0 0 0 1 0
1123 0 0 1 0 0 0 0 0 0
1125 0 0 0 0 0 0 0 0 1
1126 1 0 0 0 0 0 0 0 0
1150 0 0 1 0 0 0 0 0 1
1162 1 0 0 0 0 0 0 0 0
1163 0 1 0 0 1 1 1 0 1
1173 1 0 0 0 0 0 0 0 0
1185 1 0 0 0 0 0 0 0 1
1186 0 0 0 0 0 0 0 0 1
1187 1 0 0 0 0 0 0 0 1
1189 0 0 0 0 0 0 0 0 1
1196 0 0 0 0 0 0 0 0 1
Cytokine Samples per Subject per Week
1 10 2 3 4 5 6 7 8 9 BL Post TPN
1100 0 0 0 1 1 1 1 0 0 1 0 1
1101 0 1 1 0 1 0 1 0 1 1 0 0
1107 1 0 1 0 1 0 0 0 0 0 1 1
1108 1 0 1 0 1 1 0 0 0 0 1 0
1110 1 0 1 0 0 0 0 0 0 0 0 1
1111 1 0 1 0 0 0 0 0 0 0 1 1
1114 0 0 0 0 1 0 0 0 0 0 1 0
1125 0 0 0 0 0 0 0 0 0 0 1 1
1126 1 0 1 0 0 0 0 0 0 0 0 1
1128 1 0 0 0 0 0 0 0 0 0 0 1
1150 0 0 1 0 0 0 0 0 0 0 0 1
1162 1 0 0 0 0 0 0 0 0 0 0 0
1163 1 1 0 0 0 1 0 1 1 0 0 0
1168 1 0 1 0 0 0 0 0 0 0 0 0
1169 1 0 0 0 0 0 0 0 0 0 0 0
1173 1 0 0 0 0 0 0 0 0 0 0 0
1177 0 0 1 1 0 0 0 0 0 0 0 0
1185 1 0 0 0 0 0 0 0 0 0 0 1
1186 0 0 0 0 0 0 0 0 0 0 0 1
1187 0 0 0 0 0 0 0 0 0 0 1 1
1189 1 0 0 0 0 0 0 0 0 0 0 1
1190 0 0 0 0 0 0 0 0 0 0 0 1
1192 1 0 0 0 0 0 0 0 0 0 0 1
1194 0 0 0 0 0 0 0 0 0 0 1 1
1196 0 0 0 0 0 0 0 0 0 0 0 1
1198 1 0 0 0 1 0 0 0 0 0 0 0
1200 0 0 0 0 0 0 0 0 0 0 0 1
Sterol Samples per Subject per Week
1 10 2 3 4 5 6 7 8 9 BL Post TPN
1100 1 0 0 1 1 1 1 0 0 1 1 0
1101 0 1 1 0 1 0 1 0 1 1 0 1
1107 1 0 1 0 1 1 0 0 0 0 1 1
1108 1 0 1 0 1 0 0 0 0 0 1 0
1110 1 0 1 0 0 0 0 0 0 0 1 1
1111 0 0 1 0 0 0 0 0 0 0 1 1
1114 0 0 1 0 1 0 0 0 0 0 1 0
1123 0 0 1 1 0 0 0 0 0 0 0 0
1125 0 0 0 0 0 0 0 0 0 0 1 1
1126 1 0 1 0 0 0 0 0 0 0 0 1
1150 0 0 1 0 0 0 0 0 0 0 0 1
1162 1 0 0 0 0 0 0 0 0 0 0 0
1163 1 1 0 0 0 1 1 1 1 0 0 0
1168 1 0 0 0 0 0 0 0 0 0 0 0
1169 1 0 0 0 0 0 0 0 0 0 0 0
1173 1 0 0 0 0 0 0 0 0 0 0 0
1177 0 0 0 1 0 0 0 0 0 0 0 0
1185 1 0 0 0 0 0 0 0 0 0 0 1
1186 0 0 0 0 0 0 0 0 0 0 0 1
1187 0 0 0 0 0 0 0 0 0 0 1 1
1189 1 0 0 0 0 0 0 0 0 0 0 1
1190 1 0 0 0 0 0 0 0 0 0 0 1
1192 1 0 0 0 0 0 0 0 0 0 0 1
1198 0 0 0 0 1 0 0 0 0 0 0 0
1200 0 0 0 0 0 0 0 0 0 0 0 1

To come:

If sterol and bile acids are not sufficient, glucose values will be collected

Grace Kim